Merck
MRK
#49
Rank
โ‚น27.932 T
Marketcap
โ‚น11,298
Share price
-1.03%
Change (1 day)
70.72%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): โ‚น638.23

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น680.21. an increase over its 2024 EPS that were of โ‚น628.93.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025โ‚น677.397.71%
2024โ‚น628.934308.46%
2023โ‚น14.27-97.32%
2022โ‚น533.1710.92%
2021โ‚น480.6784.68%
2020โ‚น260.28-27.2%
2019โ‚น357.5163.44%
2018โ‚น218.74151.11%
2017โ‚น87.11-54.58%
2016โ‚น191.7730.21%
2015โ‚น147.27-61.99%
2014โ‚น387.42180.51%
2013โ‚น138.11-31.82%
2012โ‚น202.576.62%
2011โ‚น189.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,036 52.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น669.95-1.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น126.55-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น348.96-48.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,142 214.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,333 96.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น192.16-71.75%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น321.95-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น350.61-48.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น115.38-83.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel